0001415889-24-006823.txt : 20240305 0001415889-24-006823.hdr.sgml : 20240305 20240305180027 ACCESSION NUMBER: 0001415889-24-006823 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240301 FILED AS OF DATE: 20240305 DATE AS OF CHANGE: 20240305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Smith Nicholas Conrad CENTRAL INDEX KEY: 0002009130 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41944 FILM NUMBER: 24722919 MAIL ADDRESS: STREET 1: C/O ALTO NEUROSCIENCE, INC. STREET 2: 369 SOUTH SAN ANTONIO ROAD CITY: LOS ALTOS STATE: CA ZIP: 94022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alto Neuroscience, Inc. CENTRAL INDEX KEY: 0001999480 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 834210124 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 369 SOUTH SAN ANTONIO RD. CITY: LOS ALTOS STATE: CA ZIP: 94022 BUSINESS PHONE: 773-255-5012 MAIL ADDRESS: STREET 1: 369 SOUTH SAN ANTONIO RD. CITY: LOS ALTOS STATE: CA ZIP: 94022 4 1 form4-03052024_060303.xml X0508 4 2024-03-01 0001999480 Alto Neuroscience, Inc. ANRO 0002009130 Smith Nicholas Conrad C/O ALTO NEUROSCIENCE, INC. 369 SOUTH SAN ANTONIO ROAD LOS ALTOS CA 94022 false true false false CHIEF FINANCIAL OFFICER 0 Common Stock 2024-03-01 4 A 0 19153 0 A 20716 D Employee Stock Option (Right to Buy) 14.88 2024-03-01 4 A 0 90000 0 A 2034-02-28 Common Stock 90000 90000 D Represents a restricted stock unit ("RSU") award. The RSUs shall vest in two equal installments on September 1, 2025 and March 1, 2026, subject to the Reporting Person's continuous service through each such vesting date. Each RSU represents a contingent right to receive one share of common stock. 25% of the shares underlying the option shall vest on March 1, 2025, and one forty-eighth (1/48th) of the shares underlying the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date. /s/ Erin R. McQuade, Attorney-in-Fact 2024-03-05